Skip to main content
Michael Davies, MD, Oncology, Houston, TX

MichaelA.DaviesMD

Oncology Houston, TX

Melanoma

Assistant Professor

Dr. Davies is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Davies' full profile

Already have an account?

  • Office

    1515 Holcombe Blvd
    Houston, TX 77030
    Phone+1 713-792-6161
    Fax+1 713-563-3424

Education & Training

  • University of Texas Health Science Center at Houston
    University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 2004 - 2007
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 2001 - 2004
  • McGovern Medical School at UTHealth
    McGovern Medical School at UTHealthClass of 2001

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • WA State Medical License
    WA State Medical License 2023 - 2026
  • AL State Medical License
    AL State Medical License 2023 - 2025
  • AZ State Medical License
    AZ State Medical License 2023 - 2025
  • GA State Medical License
    GA State Medical License 2023 - 2025
  • LA State Medical License
    LA State Medical License 2023 - 2025
  • MS State Medical License
    MS State Medical License 2023 - 2025
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Author Correction: Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable Melanoma  
    Janice N Cormier, Ehab Hanna, Padmanee Sharma, Jennifer A Wargo, Isabella C Glitza, Sapna P Patel, Adi Diab, Jeffrey E Lee, Richard Royal, Randal Weber, Patrick Hwu, J..., Nature
  • Publisher Correction: Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable Melanoma  
    Scott Woodman, Alexander J Lazar, Michael A Davies, Neil Gross, Sapna P Patel, Isabella C Glitza, Ehab Hanna, Stephen Y Lai, Richard Ehlers, Amy Hessel, Padmanee Sharm..., Nature
  • Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable Melanoma  
    Richard Royal, Alexander J Lazar, Adi Diab, Sapna P Patel, Jeffrey E Lee, Padmanee Sharma, Patrick Hwu, Randal Weber, Jeffrey Gershenwald, Carol Lewis, Richard Ehlers,..., Nature
  • Join now to see all

Lectures

  • Will Targeted Therapy Replace Radiation for Melanoma Brain Metastases? 
    ASCO Annual Meeting 2019 - Chicago, IL - 6/4/2019
  • 17th Perspectives In Melanoma 
    Imedex, Baltimore, Maryland - 9/13/2013

Press Mentions

  • Physician-Scientist Focused on Improving Brain Metastases Treatment
    Physician-Scientist Focused on Improving Brain Metastases TreatmentFebruary 17th, 2023
  • New Cell-Based Therapy for Melanoma Is More Effective Than Existing Treatment, Trial Says
    New Cell-Based Therapy for Melanoma Is More Effective Than Existing Treatment, Trial SaysSeptember 10th, 2022
  • New Cell-Based Therapy for Melanoma More Effective Than Existing Treatment, Trial Finds
    New Cell-Based Therapy for Melanoma More Effective Than Existing Treatment, Trial FindsSeptember 10th, 2022
  • Join now to see all

Professional Memberships